<DOC>
	<DOCNO>NCT01359787</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety three concentration development drug compare ointment base ( vehicle ) subject Atopic Dermatitis ( AD ) .</brief_summary>
	<brief_title>Efficacy Safety Different Concentrations Mapracorat Ointment Over 4 Weeks Atopic Dermatitis ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Signed write informed consent Diagnosis atopic dermatitis accord Hanifin Rajka Criteria Willingness subject follow study procedure Willingness avoid excessive exposure diseased area natural artificial sunlight Pregnancy breastfeed Clinically relevant disease , could interfere study conduct evaluation interpretation study result Clinically manifest immunosuppressive disorder know history malignant disease History relevant drug and/or food allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>